U.S. Healthcare Generative AI Market To Reach $4.56 Billion By 2030

U.S. Healthcare Generative AI Market Growth & Trends

The U.S. healthcare generative AI market size is anticipated to reach USD 4.56 billion by 2030, growing at a CAGR of 36.4% during the forecast period, according to a new report by Grand View Research, Inc. The rising adoption of AI technologies and the growing awareness of remote patient monitoring drive the growth of the healthcare generative AI market in the U.S. According to a report by the World Economic Forum, 97% of medical data produced by hospitals annually goes unused.

Generative AI systems, which can create new content and analyze existing data, have gained popularity among professionals, including healthcare providers. Generative AI is transforming the medical field by providing valuable data for healthcare providers, such as medical image synthesis, personalized medicine, and drug discovery. It can synthesize medical data and generate notes, treatment codes, and summaries, reducing the documentation burden. It also responds to diagnosis inquiries, suggests therapy courses, and enhances diagnostic capabilities, driving the integration and adoption of AI technologies across various healthcare facets.

 Request a free sample copy or view report summary: U.S. Healthcare Generative AI Market Report

U.S. Healthcare Generative AI Market Report Highlights

• Based on component, the solutions segment dominated the market with a revenue share of around 58% in 2023, owing to the widespread adoption of smart gadgets, wearable technologies, and sensor-equipped smartphones which offer the potential to monitor patient behavior beyond professional settings

• Based on function, the medical imaging analysis segment accounted for the largest revenue share in 2023, owing to the ability to improve diagnostic accuracy and efficiency with the help of Generative Adversarial Networks

• Based on application, the clinical segment dominated the market with the largest revenue share in 2023, owing to prudent advances in information storage capacity, high computing power, and parallel processing capabilities to deliver high-end care.

U.S. Healthcare Generative AI Market Segmentation

Grand View Research has segmented the U.S. healthcare generative AI market based on component, function, application, and end-use:

U.S. Healthcare Generative AI Component Outlook (Revenue, USD Million, 2018 - 2030)

• Solutions

• Services

U.S. Healthcare Generative AI Function Outlook (Revenue, USD Million, 2018 - 2030)

• Virtual Nursing Assistants

• Robot-Assisted AI Surgery

• Administrative Process Optimization

• Medical Imaging Analysis

U.S. Healthcare Generative AI End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical Research

• Medical Centers

• Diagnostic Centers

• Others

U.S. Healthcare Generative AI Application Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical

  • Cardiovascular

  • Dermatology

  • Infectious Disease

  • Oncology

• System

  • Disease Diagnosis

  • Telemedicine

  • Electronic Health Records

  • Drug Interaction

List of Key Players in the U.S. Healthcare Generative AI Market

• Medtronic

• HCA Healthcare

• Neuralink Corporation

• Google LLC

• Microsoft Corporation

• IBM Watson

• Amazon Web Services, Inc.

• NioyaTech

• Oracle

• OpenAI